Autologous Hematopoietic Stem Cell Transplantation (AHSCT): An Evolving Treatment Avenue in Multiple Sclerosis

Autor:	Alisam Aryan, Reihane Mohammadi, Mir Davood Omrani, Sayyed Mohammad Hossein Ghaderian, Zahra Fazeli
Rok vydání:	2021
Předmět:	0301 basic medicine Oncology medicine.medical_specialty medicine.medical_treatment molecular mechanisms Life quality Review Disease Hematopoietic stem cell transplantation resetting immune system multiple sclerosis 03 medical and health sciences 0302 clinical medicine Immune system Rheumatology Internal medicine medicine autologous hematopoietic stem cells Immunology and Allergy Pharmacology (medical) In patient business.industry Multiple sclerosis Gastroenterology medicine.disease Transplantation Clinical trial 030104 developmental biology business 030217 neurology & neurosurgery transplantation
Zdroj:	Biologics : Targets & Therapy
ISSN:	1177-5491
DOI:	10.2147/btt.s267277
Popis:	Autologous hematopoietic stem cell transplantation (AHSCT) is considered as the novel approach to improve multiple sclerosis (MS) patients with disease-modifying therapies (DMTs)-resistance. The results obtained from different studies indicate that AHSCT increases the life quality of MS patients. Several factors are known to be influenced on the successful rate of AHSCT in patients with MS. The individuals aged
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35fc561c341b802423f554888e3c397e https://doi.org/10.2147/btt.s267277 Zobrazit plný text záznamu